Women Have Worse Outcomes During 36 Months After ACS

Share this content:
Women Have Worse Outcomes During 36 Months After ACS
Women Have Worse Outcomes During 36 Months After ACS

FRIDAY, Nov. 4, 2016 (HealthDay News) -- In a study published in the Nov. 1 issue of The American Journal of Cardiology, among patients with acute coronary syndrome (ACS), women were found to have a higher mortality rate than men during 36 months of follow-up.

Przemyslaw Trzeciak, M.D., Ph.D., from the Medical University of Silesia in Katowice, Poland, and colleagues analyzed 932 patients aged <40 years with ACS from the Silesia region in Poland. Participants were followed for a composite end point of death, ACS recurrence, a need for percutaneous coronary intervention, and coronary artery bypass graft surgery within 12 and 36 months after ACS.

The researchers found that within 12 months after ACS there was no significant difference in mortality (4.8 versus 3.1 percent; P = 0.29) or the composite end point (21.6 versus 16.0 percent; P = 0.14). Within the 36-month follow-up period, women had a higher incidence of the composite end point than men (28.4 versus 20.1 percent; P = 0.04), and there was a trend toward higher mortality (9.2 versus 5.0 percent; P = 0.055). In multivariate analysis, female gender was an independent risk factor for death (hazard ratio, 2.76).

"Women had a higher incidence of the composite end point and showed a tendency toward a higher mortality than the men within the 36-month follow-up period," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »